Site icon Market Stats News

Biotechnology Market Size is Forecasted to Reach US$ 1,683.52 Billion by 2030

The global biotechnology market size is forecasted to reach from US$ 793.87 billion in 2021 to US$ 1,683.52 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 8.7% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The biotechnology market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1450

Biotechnology is an interdisciplinary field that uses living creatures, biological systems, or derivatives to improve or develop procedures and outcomes for the production of healthcare products and therapies. It has a significant impact on a variety of industries, including medical and pharmaceuticals, genomics, and food and chemical manufacturing. It can be used to address a wide range of issues, including health and well-being, food and energy security, and environmental protection.

Biotechnology is an interdisciplinary field that uses living creatures, biological systems, or derivatives to improve or develop procedures and outcomes for the production of healthcare products and therapies. It has a significant impact on a variety of industries, including medical and pharmaceuticals, genomics, and food and chemical manufacturing. It can be used to address a wide range of issues, including health and well-being, food and energy security, and environmental protection.

Scope of the Biotechnology Market

Report Coverage Details
Market Size in 2021 USD 793.87 Billion
Growth Rate From 20201 to 2030 CAGR of 8.7%
Revenue Projection by 2030 USD 1,683.52 Billion
Largest Market North America
Fastest Growing Market Asia Pacific
Segments Covered Application, Technology, Region

Market Dynamics:

Drivers

Growing incidence of chronic diseases

The rate of chronic diseases has increased over a period of time. The bio-pharmacy segment is contributing towards the prevention of chronic diseases. The bio-pharmacy companies are focusing on improving individualized treatments. This will aid in the treatment of certain inherited genetic illnesses and open the way for the development of personalized procedural healthcare requirements. In addition, the new concepts are being introduced into the market, such as cell therapy for certain cancer treatments, which has the potential to deliver treatment of diseases effectively. Thus, the growing incidences of chronic diseases are driving the growth of biotechnology market during the forecast period.

Restraints

High equipment costs

With the advancements of biotechnologies, there is a growing demand for easy-to-use bioinformatics tools. Bioinformaticians do not make up the majority of experimental researchers. As a result, user-friendly tools are essential for bioinformatics platform utilization. Because they lack a proper user-friendly interface, many bioinformatics applications necessitate significant computer knowledge. The utilization and implementation of biotechnology equipment require huge amount of capital. Thus, the high equipment costs are hindering the growth of biotechnology market during the forecast period.

Opportunities

Technological advancements

By utilizing innovative technologies, growing developments in life sciences are providing several benefits related with healthcare treatments and productivity. The development of innovative techniques and their deployment by businesses has a beneficial impact on the biotechnology market and is expected to promote significant market growth. In medical, cutting-edge technology are used to generate certain components of the human body. By offering exact models for study and analysis, the ability to produce human cells and tissues would broaden the spectrum of applications in medical research. Thus, the technological advancements is creating lucrative opportunities for the growth of the biotechnology market.

Challenges

Patient data confidentiality concerns

The increase in number of chronic diseases has led to increase in number of patients. The bio-informatics helps to store data of patients on a large scale. All this information is stored in next-generation sequencing technology. As a lot of information is still untapped, data analysis is required. As a result, the data left behind from bioinformatics analysis is extremely valuable and can be reused. The problems of data management in bioinformatics are not effectively addressed by current technologies. Thus, the patient data confidentiality is a biggest challenge for the growth of biotechnology market during the forecast period.

Report Highlights

Regional Snapshot

North America is the largest segment for biotechnology market in terms of region. The biotechnology market in North America is being driven by the rising burden of chronic disease and increased expenditure on research and development activities in the U.S. The U.S. is known as the world’s life sciences innovation capital center.

Asia-Pacific region is the fastest growing region in the biotechnology market. Due to increased R&D investment, increased use and availability of biopharmaceuticals for illness and disease treatment, and increased disease diagnosis awareness, the Asia-Pacific region is expected to grow significantly in the future. Furthermore, because the developed markets are somewhat saturated, the Asia-Pacific region represents exceptional potential for venture capitalists and investors.

Competitive Landscape Analysis:

Some of the leading companies operating in the biotechnology market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

Segments Covered in the Report

By Application

By Technology

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global biotechnology market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for biotechnology are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1450

TABLE OF CONTENT

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotechnology Market 

5.1. COVID-19 Landscape: Biotechnology Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotechnology Market, By Technology

8.1. Biotechnology Market, by Technology Type, 2021-2030

8.1.1. Fermentation

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Tissue Engineering and Regeneration

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Polymerase Chain Reaction (PCR) Technology

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Nanobiotechnology

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Chromatography

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Deoxyribonucleic Acid (DNA) Sequencing

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Cell Based Assay

8.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Biotechnology Market, By Application

9.1. Biotechnology Market, by Application, 2021-2030

9.1.1. Bio-pharmacy

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Bio-industries

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Bio-services

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Bio-agriculture

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Bio-informatics

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Biotechnology Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Technology (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Technology (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Technology (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Technology (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Technology (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Technology (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Technology (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Technology (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Technology (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Technology (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Technology (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

Chapter 11. Company Profiles

11.1. Lonza

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. AstraZeneca

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Pfizer Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Gilead Sciences Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. F. Hoffmann-La Roche Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Biogen

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. CELGENE Corporation

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Sanofi

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Abbott

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Novartis AG

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1450

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Exit mobile version